Microdermabrasion in Austria
Microdermabrasion in Austria section, includes general infrmation about Microdermabrasion Procedure, Microdermabrasion Austria Local News, Microdermabrasion Austria Surgeon Locator and other Microdermabrasion related material.
Microdermabrasion Procedure
Microdermabrasion is one of the most popular non-invasive cosmetic procedures performed today. Over time, factors such as aging, genetic factors, sun damage, acne, scarring, and enlarged pores can contribute to the formation of facial wrinkles and a rough skin texture on the face. Most commonly used to treat the face and neck, microdermabrasion can successfully reduce the appearance of superficial wrinkles and scars, large pores, acne, and age spots, restoring a smoother, more youthful appearance.
Before you learn how microdermabrasion can rejuvenate your skin, you need to understand what makes up your skin. Your skin consists of two layers known as the epidermis and the dermis. The epidermis, or outer layer of the skin, acts as the skin’s primary defense against the environment, and sustains the most damage from the sun. The effects of sun damage are what cause the skin to have a rough appearance. Beneath the epidermis lies the dermis, or innermost layer of the skin, which provides structure and support.
The dermis is comprised primarily of connective tissue, which is made mostly of collagen and elastin fibers. These fibers form a network that provides the skin with structure, support, and elasticity. Over time, the aging process and sun damage cause a decrease in the amount of collagen and elastin fibers. As this network of fibers breaks down, the skin loses its elasticity and becomes more lax. Together, aging, sun damage, and other factors contribute to wrinkle formation and other changes in appearance.
During microdermabrasion, fine crystals usually remove the superficial or uppermost layer of the epidermis, known as the stratum corneum. Depending on the extent of skin damage, deeper treatment may be necessary; however, treatment rarely extends beyond the epidermis. As a result, microdermabrasion is not appropriate for the treatment of deeper wrinkles and scars, or extensive discoloration as these conditions likely extend into the dermis. In these instances chemical peels and laser resurfacing may achieve more desirable results. As microdermabrasion only causes superficial injury to the skin, the risk of scarring and pigmentation anomalies following microdermabrasion is extremely low, when compared with other resurfacing techniques. Therefore, microdermabrasion can be safely and effectively used on individuals of all skin types.
A microdermabrasion procedure may last approximately thirty to forty five minutes. Unlike certain chemical peels and laser resurfacing, the procedure is relatively painless; therefore anesthesia is not typically required. Prior to your procedure, your physician may recommend that you treat your skin with products containing alphahydroxy acid or retinoic acid, among others, which may increase the effects and longevity of your treatment. Before the treatment, your face will be thoroughly cleansed, usually using an alcohol-based cleanser. Your physician may also provide you with goggles to protect your eyes during the procedure.
During the procedure, the physician uses a device which emits pressurized crystals on to the surface of the skin. Using single strokes, the physician will guide the device over the treatment area to remove damaged skin layers.
The hand piece releases fine, pressurized crystals, which much like sandblasting exfoliate the stratum corneum, or the skin’s outermost layer. In areas with more damage, the physician may increase the amount of pressure exerted by the device or the number of passes made in the area. This will cause the treatment, or amount of injury, to extend deeper into the skin. A vacuum sucks the used crystals and exfoliated skin particles back into the device, so that they can be removed and discarded.
Following your microdermabrasion procedure, you may experience some redness for the first few hours, but you will be able to return to your normal routine immediately after your treatment. Your physician may apply a cream or ointment to the treatment areas to keep them moist as they heal. It is important that you continue to use these products as directed by your physician, as your skin may continue to exfoliate following the procedure. Your skin may appear as if you have a minor sunburn for two to three days and will be more sensitive to sunlight. Therefore, it is important that you use sunscreen with SPF 15 or greater as your skin heals.
As the new skin cells are revealed, your skin will have an improved texture and overall appearance. It is important to realize that in order to maintain the results from a microdermabrasion procedure, you will likely have to undergo approximately five to ten treatments, depending on the severity of skin damage. Initially, you may receive treatments every one to two weeks. However, over time the frequency of treatment may decrease to once a month, and later to twice a year. Although multiple treatments are required, microdermabrasion is a simple, fast, effective method of reducing superficial skin damage to restore a refreshed and youthful appearance.
Other Microdermabrasion Procedures
All Skin Procedures
Microdermabrasion Austria (current)
Microdermabrasion Austria Chemical Peel
Microdermabrasion Austria Dermabrasion
Microdermabrasion Austria Laser Hair Removal
Microdermabrasion Austria Collagen Injections
More Austria info...
Austria History Once the center of power for the large Austro-Hungarian Empire, Austria was reduced to a small republic after its defeat in World War I. Following annexation by Nazi Germany in 1938 and subsequent occupation by the victorious Allies in 1945, Austria's status remained unclear for a decade. A State Treaty signed in 1955 ended the occupation, recognized Austria's independence, and forbade unification with Germany. A constitutional law of that same year declared the country's "perpetual neutrality" as a condition for Soviet military withdrawal. This neutrality, once ingrained as part of the Austrian cultural identity, has been called into question since the Soviet collapse of 1991 and Austria's entry into the European Union in 1995. A prosperous country, Austria entered the European Monetary Union in 1999.
Austria Climate Austria has a temperate continental climate. Summers last from early June to mid-September and can be hot in some years and rainy in others. Day-time temperatures in July and August are around 25° C (77° F), but can often reach 35° C (95° F). Winters are cold in the lowlands and very harsh in the Alpine region with temperatures often dropping below -10° C (14° F). Winters last from December to March (longer at higher altitudes). In the Alpine region large temperature fluctuations occur all year round and nights are chilly even in high summer. The northern Alps are generally a lot wetter than the rest of the country. The South East (Styria and Carinthia) is dry and sunny. The area around Vienna often experiences strong easterly winds.
Plastic Surgery News...
- The National Prescribing Centre (NPC) has produced a “blog” discussing a recently published meta-analysis which concluded that statin therapy should be considered for all diabetic individuals who are at sufficiently high risk of vascular events (Lancet 2008; 371:117-125).
The blog discusses the results of the meta-analysis, and concludes that “Clinicians should continue to perform CV risk assessment in patients with diabetes (either clinically or using an approved assessment tool). While the majority of people with diabetes will fulfil the criteria for consideration of a statin (CV risk greater than 20% over ten years) some will not. Even those who do may choose not to take a statin and may prefer to undertake other, non-drug methods of risk reduction. Certainly, other factors should not be forgotten e.g. smoking cessation, blood pressure control, antiplatelet therapy, and blood glucose control.”
- La Jolla Pharmaceutical Company (Nasdaq:LJPC) announced significant progress in its ongoing double-blind, placebo-controlled randomized Phase 3 trial of Riquent(R) (abetimus sodium), its drug candidate for systemic lupus erythematosus ("lupus" or "SLE"), including additional safety data on the trial's higher doses.